Changes in Quality of Life Domains among Saudi Patients with Systemic Lupus Erythematosus before and during the COVID-19 Pandemic

ORIGINAL ARTICLE
Howeida Abusalih, Sarah Almanea, Dhai Alotaib, Lama Alotaibi, Seba Monshi, Asma Alanazi, Anwar Alhashem

 
For citation: Abusalih H, Almanea S, Alotaib D, Alotaibi L, Monshi S, Alanazi A, Alhashem A. Changes in Quality of Life Domains among Saudi Patients with Systemic Lupus Erythematosus before and during the COVID-19 Pandemic. International Journal of Biomedicine. 2024;14(4):673-678. doi:10.21103/Article14(4)_OA22
 
Originally published December 5, 2024
 

Abstract: 

Background: Systemic lupus erythematosus (SLE) is the most prevalent form of lupus. In this autoimmune disease, the immune system attacks the body's tissues, causing systemic damage and inflammation. This research aimed to measure the quality of life (QoL) among adult SLE patients before and during COVID-19 in Saudi Arabia.
Methods and Results: A cross-sectional descriptive study was conducted in Riyadh City between November 2021 and March 2022. Data were collected from 192 patients (172 women and 20 men) with SLE via social media platforms (Twitter, Telegram, WhatsApp, and Instagram) using the Short Form-36 (SF-36) questionnaire. All eight QoL domains and overall health changes revealed significant differences before and during the COVID-19 pandemic. For all scales and the single health change item, there was a decline in QoL; moreover, most show a decrease in the range of 10 points on the 100-point scale. None of the correlations between age and QoL measures were high. For both men and women, general health was reported to be better before COVID-19 than during the pandemic, as expected. Due to a much larger number of women than men in the study, the significance of that decline in general health resulted in a higher significance level for women (t = 5.69, P<0.001) than for men (t = 2.07, P<0.05). However, the Hedges’ g effect size estimate was higher for men (g=0.47) than for women (g=0.30).
Conclusion: The QoL of SLE patients was generally lower before and even more so during the COVID-19 pandemic. This change is not correlated with any sociodemographic factors.

Keywords: 
systemic lupus erythematosus • COVID-19 • SF-36 • quality of life • Saudi Arabia
References: 
  1. Center for Disease Control and Prevention. Lupus Basics. Available from: https://www.cdc.gov/lupus/about/index.html
  2. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011 Oct;6(4):330-6. PMID: 22879850; PMCID: PMC3391953.
  3. García-Carrasco M, Pinto CM, Poblano JCS, Morales IE, Cervera R, Anaya J-M. Chapter 25. Systemic lupus erythematosus. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459474/
  4. The World Health Organization Quality of Life (WHOQOL). 1 March 2012 Guidance (normative) Available from: https://www.who.int/publications/i/item/WHO-HIS-HSI-Rev.2012.03
  5. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016 Oct 4;4:2050312116671725. doi: 10.1177/2050312116671725. PMID: 27757230; PMCID: PMC5052926.
  6. Olesińska M, Saletra A. Quality of life in systemic lupus erythematosus and its measurement. Reumatologia. 2018;56(1):45-54. doi: 10.5114/reum.2018.74750. Epub 2018 Feb 28. PMID: 29686443; PMCID: PMC5911658.
  7. Kuriya B, Gladman DD, Ibañez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008 Feb 15;59(2):181-5. doi: 10.1002/art.23339. PMID: 18240183.
  8. Panopalis P, Clarke AE. Quality of life in systemic lupus erythematosus. Clin Dev Immunol. 2006 Jun-Dec;13(2-4):321-4. doi: 10.1080/17402520600877760. PMID: 17162373; PMCID: PMC2270782.
  9. Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R, Serrano-Aguilar P; Spanish SLE CPG Development Group. Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. Semin Arthritis Rheum. 2016 Feb;45(4):463-70. doi: 10.1016/j.semarthrit.2015.09.003. Epub 2015 Oct 1. PMID: 26522137.
  10. McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus. 2010 Dec;19(14):1640-7. doi: 10.1177/0961203310378668. Epub 2010 Aug 13. PMID: 20709719.
  11. Beckerman NL, Auerbach C, Blanco I. Psychosocial dimensions of SLE: implications for the health care team. J Multidiscip Healthc. 2011 Apr 5;4:63-72. doi: 10.2147/JMDH.S19303. PMID: 21594059; PMCID: PMC3093952.
  12. Ciurea A, Papagiannoulis E, Bürki K, von Loga I, Micheroli R, Möller B, Rubbert-Roth A, Andor M, Bräm R, Müller A, Dan D, Kyburz D, Distler O, Scherer A, Finckh A. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2021 Feb;80(2):238-241. doi: 10.1136/annrheumdis-2020-218705. Epub 2020 Sep 22. PMID: 32963052.
  13. Ziadé N, Hmamouchi I, El Kibbi L, Abdulateef N, Halabi H, Abutiban F, Hamdi W, El Rakawi M, Eissa M, Masri B. The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study. Clin Rheumatol. 2020 Nov;39(11):3205-3213. doi: 10.1007/s10067-020-05428-2. Epub 2020 Sep 30. PMID: 32996071; PMCID: PMC7524572.
  14. Algahtani FD, Hassan SU, Alsaif B, Zrieq R. Assessment of the Quality of Life during COVID-19 Pandemic: A Cross-Sectional Survey from the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2021 Jan 20;18(3):847. doi: 10.3390/ijerph18030847. PMID: 33498152; PMCID: PMC7863741.
  15. Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev. 2021 Sep;20(9):102883. doi: 10.1016/j.autrev.2021.102883. Epub 2021 Jul 5. PMID: 34237419; PMCID: PMC8256657.
  16. Santos-Ruiz A, Montero-López E, Ortego-Centeno N, Peralta-Ramírez MI. Effect of COVID-19 confinement on the mental status of patients with systemic lupus erythematosus. Med Clin (Engl Ed). 2021 Apr 23;156(8):379-385. doi: 10.1016/j.medcle.2020.12.009. Epub 2021 Mar 18. PMID: 33754127; PMCID: PMC7969859.
  17. Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford). 2021 Oct 9;60(SI):SI37-SI50. doi: 10.1093/rheumatology/keab250. PMID: 33725121; PMCID: PMC7989171.
  18. Ministry of Health, Saudi Vision 2030. 2019. Healthcare Transformation Strategy. Available from: https://www.moh.gov.sa/en/Ministry/vro/Pages/Health-Transformation-Strat...
  19. Islam MM, Alharthi M. Impact of COVID-19 on the Quality of Life of Households in Saudi Arabia. Int J Environ Res Public Health. 2022 Jan 29;19(3):1538. doi: 10.3390/ijerph19031538. PMID: 35162560; PMCID: PMC8835156.
  20. Plantinga LC, Hoge C, Dunlop-Thomas C, Pearce BD, Lim SS, Drenkard C, Bowling CB. Association of COVID-19 pandemic-related concern and health routine changes with functioning among individuals with systemic lupus erythematosus. Lupus Sci Med. 2022 Feb;9(1):e000658. doi: 10.1136/lupus-2022-000658. PMID: 35177480; PMCID: PMC8889448.
  21. Lupus Foundation of America. 2021. COVID-19 and Lupus. Available online: https://www.lupus.org/resources/coronavirus-and-lupus
  22. Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, Atagunduz P, Tuglular S, Direskeneli H. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clin Rheumatol. 2016 Mar;35(3):617-22. doi: 10.1007/s10067-015-2930-1. Epub 2015 Apr 7. PMID: 25846834.
  23. Gaballah, N.M.; El-Najjar, A.R. Clinical characteristics and health related quality of life (HRQoL) in Egyptian patients with systemic lupus erythematosus. Egypt Rheumatol. 2019;41:117–121. doi: 10.1016/j.ejr.2018.07.003.

Download Article
Received October 9, 2024.
Accepted November 6, 2024.
©2024 International Medical Research and Development Corporation.